Pricing Log in Create free account

Arvinas, Inc. (ARVN) vs Valneva SE Sponsored ADR (VALN)

Arvinas, Inc. and Valneva SE Sponsored ADR are both Biotechnology companies. Arvinas, Inc. and Valneva SE Sponsored ADR are of similar size ($518.5M and $513.9M). Arvinas, Inc. trades at the lower P/E: 39.5× against 56.7×. Arvinas, Inc. grew revenue faster over the last twelve months: −15.1% against −53.2%. Arvinas, Inc. has the higher net margin (2.94% vs −12.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 19 metrics below, Arvinas, Inc. leads on 15 and Valneva SE Sponsored ADR on 4.

Valuation

Metric ARVN VALN Biotechnology median
P/E 39.48 56.70 10.71
P/S 1.55 2.89 9.84
P/B 0.87 5.03 2.15
Price to free cash flow n/m n/m 25.78
EV/EBITDA 4.27 41.04 0.65
EV/Sales (0.24) 3.34 9.47
Earnings yield 2.53% 1.76% (34.53%)
Free cash flow yield (42.62%) (12.40%) (24.00%)

Profitability

Metric ARVN VALN Biotechnology median
Gross margin 97.16% 38.28% 69.20%
Operating margin (5.72%) 13.56% 0.00%
Net margin 2.94% (12.01%) 0.00%
Free cash flow margin (65.93%) 0.00% 0.00%
Return on equity 1.59% 0.00% (53.10%)
Return on assets 1.17% 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARVN VALN Biotechnology median
Revenue growth (TTM) (15.05%) (53.16%) 5.26%
EPS growth (last fiscal year) 58.84% (805.88%) 29.88%
Revenue growth, 5-year CAGR 58.93% 9.41% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARVN VALN Biotechnology median
Debt to equity 0.00 2.27 0.00
Current ratio 7.91 2.16 4.98
Net debt to EBITDA 5.62 (1.15) 1.01

Dividend

Metric ARVN VALN Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ARVN VALN Biotechnology median
Market cap 513.94m 518.46m 171.46m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack